Zura Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	223	204	176	170
Market Cap Growth	46.12%	15.59%	3.44%	-
Enterprise Value	133	104	182	170
PE Ratio	-	-2.94	-5.44	24.86
PB Ratio	3.65	3.43	-5.49	-18.55
P/FCF Ratio	-6.67	-13.52	-146.52	-155.04
P/OCF Ratio	-6.68	-13.52	-146.52	-155.04
EV/EBITDA Ratio	-0.38	-1.72	-7.08	24.75
EV/EBIT Ratio	-0.38	-1.72	-7.08	24.75
EV/FCF Ratio	-1.32	-6.89	-151.67	-154.38
Debt / Equity Ratio	-	-	-0.24	-
Debt / EBITDA Ratio	-	-	-0.30	-
Debt / FCF Ratio	-	-	-6.45	-
Quick Ratio	6.12	4.92	0.11	2.68
Current Ratio	6.17	4.97	0.12	4.23
Return on Equity (ROE)	-95.30%	-126.30%	235.20%	-99.50%
Return on Assets (ROA)	-58.80%	-76.30%	-30.40%	7.30%
Return on Capital (ROIC)	-103.75%	-105.58%	111.78%	9.68%
Earnings Yield	-27.05%	-34.01%	-18.39%	4.02%
FCF Yield	-7.55%	-7.39%	-0.68%	-0.64%
Buyback Yield / Dilution	-1220.83%	-14392.36%	97.95%	-
Total Shareholder Return	-1220.83%	-14392.36%	97.95%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).